Managing adverse events of sacituzumab govitecan
.
Source: Expert Opinion on Biological Therapy - Category: Drugs & Pharmacology Authors: Ilana SchlamPaolo TarantinoSara M. Tolaneya Department of Hematology and Oncology, Tufts Medical Center, Boston, MA, USAb Department of Medicine, Tufts University, Boston, MA, USAc Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAd Breast On Source Type: research